(Q39826501)

15 September 2017

title

Analysis of 75 marketed pharmaceuticals using the GADD45a-GFP 'GreenScreen HC' genotoxicity assay (English)

1 reference

15 September 2017

1 reference

Paul W Hastwell

1

1 reference

15 September 2017

Thomas W Webster

2

1 reference

15 September 2017

Matthew Tate

3

1 reference

15 September 2017

Nicholas Billinton

4

1 reference

15 September 2017

Anthony M Lynch

5

1 reference

15 September 2017

James S Harvey

6

1 reference

15 September 2017

Robert W Rees

7

1 reference

15 September 2017

Richard M Walmsley

8

1 reference

15 September 2017

publication date

10 July 2009

1 reference

15 September 2017

1 reference

15 September 2017

volume

24

1 reference

15 September 2017

issue

5

1 reference

15 September 2017

page(s)

455-463

1 reference

High-specificity and high-sensitivity genotoxicity assessment in a human cell line: validation of the GreenScreen HC GADD45a-GFP genotoxicity assay

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FMUTAGE%2FGEP029

The utility of DNA microarrays for characterizing genotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMUTAGE%2FGEP029

Assessment of the genotoxicity of S9-generated metabolites using the GreenScreen HC GADD45a-GFP assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMUTAGE%2FGEP029

Development and validation of a higher throughput screening approach to genotoxicity testing using the GADD45a-GFP GreenScreen HC assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMUTAGE%2FGEP029

Genotoxic carcinogen or not genotoxic carcinogen? That is the question Re: Olaharski et al., "Validation of the GreenScreen GADD45alpha-GFP indicator assay with non-proprietary and proprietary compounds".

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMUTAGE%2FGEP029

The history of the oxazaphosphorine cytostatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMUTAGE%2FGEP029

Describing the validity of carcinogen screening tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMUTAGE%2FGEP029

Identification of rodent carcinogens and noncarcinogens using genetic toxicity tests: premises, promises, and performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMUTAGE%2FGEP029

Genotoxicity of 17 gyrase- and four mammalian topoisomerase II-poisons in prokaryotic and eukaryotic test systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMUTAGE%2FGEP029

Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMUTAGE%2FGEP029

An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMUTAGE%2FGEP029

Evaluation of the GreenScreen GADD45alpha-GFP indicator assay with non-proprietary and proprietary compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMUTAGE%2FGEP029

Cell cycle arrest at the initiation step of human chromosomal DNA replication causes DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMUTAGE%2FGEP029

Anticancer Antifolates: Current Status and Future Directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMUTAGE%2FGEP029

The photomutagenicity of fluoroquinolones in tests for gene mutation, chromosomal aberration, gene conversion and DNA breakage (Comet assay).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMUTAGE%2FGEP029

Late incidence of cancer after metronidazole use: a matched metronidazole user/nonuser study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMUTAGE%2FGEP029

SFTG international collaborative study on in vitro micronucleus test I. General conditions and overall conclusions of the study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMUTAGE%2FGEP029

21 January 2018

Identifiers

DOI

10.1093/MUTAGE/GEP029

1 reference

15 September 2017

1 reference